NVCT (Nuvectis Pharma) Insider Ownership: 25.97 % (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVCT Nuvectis Pharma Inc NVCT
22 GF Score
Price $25.89
! 1 Warning Sign
View Full Analysis

What is Nuvectis Pharma Insider Ownership?

Nuvectis Pharma NVCT +8.33% 22 Insider Ownership is 25.97 % as of Aug. 25, 2026. GuruFocus rates NVCT with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nuvectis Pharma's insider ownership is 25.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nuvectis Pharma's Institutional Ownership is 17.60%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nuvectis Pharma's Float Percentage Of Total Shares Outstanding is 66.52%.

Nuvectis Pharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for Nuvectis Pharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvectis Pharma Insider Ownership Chart

Nuvectis Pharma Historical Data

The historical data trend for Nuvectis Pharma can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 35.03 28.75 28.75 29.18 29.55 31.56 30.33 30.33 25.97 25.97
NVCT
22GF Score
Nuvectis Pharma Inc NVCT
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvectis Pharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 25.97 % mean?
Nuvectis Pharma (NVCT) has a Insider Ownership of 25.97 % as of Aug. 25, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Nuvectis Pharma and its competitors.
Is Nuvectis Pharma's Insider Ownership too high?
Nuvectis Pharma's current Insider Ownership is 25.97 %. Overall, Nuvectis Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Nuvectis Pharma's Insider Ownership compare to IMMX and CBIO?
Nuvectis Pharma's Insider Ownership of 25.97 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Nuvectis Pharma and its competitors. Nuvectis Pharma's current Insider Ownership is 25.97 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvectis Pharma stock overvalued right now?
Nuvectis Pharma (NVCT) has a current Insider Ownership of 25.97 %. The current Insider Ownership is 25.97 %. Nuvectis Pharma's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Nuvectis Pharma (NVCT), the current Insider Ownership is 25.97 % as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuvectis Pharma Business Description

Address 1 Bridge Plaza, 2nd Floor, Suite 275, Fort Lee, NJ, USA, 07024
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
22GF Score

Get the complete analysis for NVCT

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.89
Price